WebbExhibit 10.1 . ACELYRIN, INC. 2024 STOCK OPTION AND GRANT PLAN . SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS. The name of the plan is the ACELYRIN, INC. 2024 Stock Option and Grant Plan (the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key … Webb5 jan. 2024 · "I have longstanding respect for Shao-Lee and her colleagues at ACELYRIN, and firmly believe that they are best suited to further advance these immunology assets …
ACELYRIN Scores $250 Million to Progress Innovative Antibody
Webbför 18 timmar sedan · Acelyrin founder and chief executive Shao-Lee Lin Initial public offerings in the biotech sector nosedived last year after a lot of activity in 2024, but have remained few and far between this ... Webb12 apr. 2024 · Acelyrin. 于 2024 年 9 月宣布完成 3 亿美元的 C 轮融资。 投资方包括 OrbiMed、Samsara BioCapital 等。 Acelyrin 由 Horizon Therapeutics 的两位高管 Shao … culture gender entertainment and sport
ACELYRIN Company Profile - Office Locations, Competitors, …
WebbShao-Lee Lin is co-founder and chief executive at ACELYRIN. "[Carey] contributed tremendously to the transformation of [Horizon] from sort of a specialty pharma … WebbDawn Svoronos atualmente é Chairman of the Board da Theratechnologies, Director da Acelyrin e Director da Adverum Biotechnologies. Dawn Svoronos estudado em Carleton University. ... Na Acelyrin, Dawn Svoronos possui 20 colleagues incluindo Shao-Lee Lin (CEO & Director), ... WebbACELYRIN has 5 current employee profiles, including Chief Medical Officer Paul M. Peloso. Paul M. Peloso Chief Medical Officer. Shao-Lee Lin Founder and CEO. Melanie Gloria … culture globalization brings us together